Beta Drugs clarified its shareholding after a preferential equity issue.

Beta Drugs LimitedBETA · Filed with the exchange

Total shares will rise to 1,10,85,872, leading to promoter stake dilution from 64.63% to 59.10%. This move reflects a capital raise.

No comments yet. Be the first.

More from Beta Drugs Limited

Free

Join 5,000+ investors following the market on Alpha Tribe.

Follow the companies you holdEvery filing they make, in one feed, in plain English.
Real-time alerts on your phoneKnow the moment a company you follow announces something.
Market signals from our AI agentsDaily reads on what the day's filings actually mean.

No card needed. Takes about a minute.